Skip to main content

Day: June 18, 2021

BioXcel Therapeutics to Host Virtual Commercial Day on June 25, 2021

Live webcast to be held on June 25th from 12:00 PM ET – 1:30 PM ET NEW HAVEN, Conn., June 18, 2021 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Commercial Day on Friday, June 25, 2021, from 12:00 PM ET – 1:30 PM ET. The event aims to provide an update on the Company’s launch readiness plans and market insights for BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia and bipolar disorders I and II in adults, along with a key opinion leader...

Continue reading

View Smart Windows Selected for Renovation of 111 Wall Street, a Reimagined Office Tower in Manhattan’s Financial District

111 Wall Street111 Wall StreetNEW YORK and MILPITAS, Calif., June 18, 2021 (GLOBE NEWSWIRE) — View, Inc. (Nasdaq: VIEW) (“View”), the market leader in smart glass, announced its smart windows will be installed at 111 Wall Street, a 25-story, 1.2 million-square-foot waterfront office tower in Manhattan’s Financial District, currently undergoing an extensive transformation by Nightingale Properties and Wafra Capital Partners. Nightingale Properties and Wafra Capital Partners are repositioning 111 Wall Street into a Class-A downtown New York City office asset through a redevelopment program that includes a full exterior renovation and infrastructure overhaul. View Smart Windows, which use artificial intelligence to optimize natural light and views of the outdoors while minimizing heat and glare, will serve as a key...

Continue reading

AnPac Bio’s First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds

PHILADELPHIA, June 18, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection as well as cancer treatment, announced today that it has been granted its first disease treatment patent by the United States Patent and Trademark Office on June 7, 2021. The patent covers novel medical devices for both disease detection and treatment applications and has 25 claims. This patent covers novel device structures and methods to modify biological samples for treatment purposes. This latest patent is the twenty first patent granted to AnPac Bio in the United States. The Company also announced that its newly launched cancer treatment joint venture has secured, via signed...

Continue reading

Hexagon Agility receives order from REV LNG for Mobile Pipeline® modules to deliver Renewable Natural Gas

Hexagon Agility has received an order for Mobile Pipeline® modules from REV LNG, LLC a leading full-service mobile energy supply and project development company. These modules will be used to transport and deliver renewable natural gas (RNG). This order represents an estimated value of USD 7.8 million (approx. NOK 67 million).    “Mobile Pipeline is essential to our business as we are committed to delivering RNG where pipeline infrastructure is not readily available,” said David Kailbourne, President of REV LNG. “Hexagon Agility’s TITAN®53 modules offer the safest, highest capacity, and lowest cost of ownership solutions in North America, and are instrumental to our vision and company growth.” About the market RNG results in the greatest reduction of greenhouse gas emissions of any clean energy solution available today in the transport...

Continue reading

Finance update and extension to reporting deadline

For immediate release 18 June 2021 Serabi Gold plc(“Serabi” or the “Company”) Finance update and extension to reporting deadline Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian-focused gold mining and development company, is pleased to update the market on financial performance for the year to date and to provide an update on the audit of the financial results for the 2020 calendar year. HighlightsFollowing the successful equity placing closed on 9 March 2021 raising gross proceeds of £12.5 million:                      –     The convertible loan notes that had been issued during 2020 (the “Loan Notes”) have been fully repaid together with accrued interest and arrangement fees (US$2.5 million).                       –     Acquisition of Coringa project completed with payments during 2021 (including accrued interest)...

Continue reading

Huize Launches “Darwin Critical Care 2021” with Sunshine Insurance Group – An Innovative Critical Insurance Product for Consumers with Pre-existing Conditions

SHENZHEN, China, June 18, 2021 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today announced that it has partnered with Sunshine Insurance Group to launch “Darwin Critical Care 2021,” a critical illness insurance product designed for sub-optimal health group. Mr. Cunjun Ma, Founder, Chairman and Chief Executive Officer of Huize, commented, “This year marks the second year in a row for Huize to launch a product dedicated to customers with pre-existing medical conditions. Leveraging our years of experience in product development, advanced technology, and a massive amount of multi-dimensional user data, we are able to group sub-optimal health users at a reasonably large scale, deploy data-analytics...

Continue reading

Adevinta welcomes Austrian regulatory approval and commences closing of the acquisition of eBay Classifieds Group

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 18 June 2021 – Following an announcement by the Austrian Federal Competition Authorities (the “FCA”) today, Adevinta ASA (ADE) (“Adevinta”), confirms that the FCA has approved the remedies proposed by Adevinta and eBay Inc. (“eBay”) to resolve the competition concerns raised by the FCA in relation to Adevinta’s acquisition of eBay Classifieds Group (“eCG”), the global classifieds arm of eBay (“the transaction”).   The remedies proposed by Adevinta and eBay address the FCA’s concern that the transaction...

Continue reading

Notice of GM

Election of Board members. It is hereby announced that Mr. Jørn Tolstrup Rohde has been elected new vice chairman of the board. It is also announced that Ms. Lene Lange has been elected as new board member.

Continue reading

The Tribbioli Simone Group: Benefits of Investing pre-IPO

Benefits of investing pre-IPO: The benefits of investing pre-IPO can be life-changing, but many investors don’t know about them or know that they can be pre-IPO investors at all. Pre-IPO investing means investing in promising companies before they go public. While many retail investors may think the first chance they have to invest is during the initial public offering (IPO), that’s no longer true. When companies are ready to list on the major stock exchanges, such as the New York Stock Exchange (NYSE) and the Nasdaq, they hold an IPO. These are the first time many people have a chance to invest in the company, but it’s not the most profitable time to invest. Reasons why pre-IPO investments make sense: Pre-IPO companies can deliver extremely high returns Investing in proven companies with a path to profitability de-risks...

Continue reading

Market session wraps with Fed decision released; major equities down

The meeting showed that more policymakers are convinced of the possible interest rate hike in the next two years. There is no immediate change on the current policy, but the new projection says that the interest rate is to increase by the end of 2022 which was supported by seven out of eighteen officials, compared to the same statement in March which was only supported by four. Also, thirteen officials now see a hike before 2023 ends, versus the original seven that agrees to this statement. This information is digested by the traders which caused stocks to pull down, hard. Another detail weighing on the traders is the economic data released on Tuesday, which showed the producer price increasing on record rate considering year on year changes. The personal consumption expenditure and the core consumer price index also rose in May to a record...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.